References
- Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311–21.
- Bainbridge KE, Hoffman HJ, Cowie CC. Diabetes and hearing impairment in the United States: audiometric evidence from the national health and nutrition examination survey, 1999 to 2004. Ann Intern Med 2008;149:1–10.
- Austin DF, Konrad-Martin D, Griest S, McMillan GP, McDermott D, Fausti S. Diabetes-related changes in hearing. Laryngoscope 2009;119:1788–96.
- Rosen S, Pleister D, El-Mofty A, Rosen HV. Relation of hearing loss to cardiovascular disease. Trans Am Acad Ophthalmol Otolaryngol 1964;68:433–44.
- Suzuki W, Iizuka S, Tabuchi M, Funo S, Yanagisawa T, Kimura M, et al. A new mouse model of spontaneous diabetes derived from ddY strain. Exp Anim 1999;48:181–9.
- Iizuka S, Suzuki W, Tabuchi M, Nagata M, Imamura S, Kobayashi Y, et al. Diabetic complications in a new animal model (TSOD mouse) of spontaneous NIDDM with obesity. Exp Anim 2005;54:71–83.
- Hirayama I, Yi Z, Izumi S, Arai I, Suzuki W, Nagamachi Y, et al. Genetic analysis of obese diabetes in the TSOD mouse. Diabetes 1999;48:1183–91.
- Vaughan N, James K, McDermott D, Griest S, Fausti S. A 5-year prospective study of diabetes and hearing loss in a veteran population. Otol Neurotol 2006;27:37–43.
- Kakarlapudi V, Sawyer R, Staecker H. The effect of diabetes on sensorineural hearing loss. Otol Neurotol 2003;24:382–6.
- Akinpelu OV, Mujica-Mota M, Daniel SJ. Is type 2 diabetes mellitus associated with alterations in hearing? A systematic review and meta-analysis. Laryngoscope 2014;124:767–76.
- Fukushima H, Cureoglu S, Schachern PA, Paparella MM, Harada T, Oktay MF. Effects of type 2 diabetes mellitus on cochlear structure in humans. Arch Otolaryngol Head Neck Surg 2006;132:934–8.
- Wackym PA, Linthicum FH. Diabetes mellitus and hearing loss: clinical and histopathologic relationships. Am J Otol 1986;7:176–82.
- Smith TL, Raynor E, Prazma J, Pillsbury HC. Insulin-dependent diabetic microangiopathy in the inner ear. Laryngoscope 1995;105:236–40.
- Lee HS, Kim KR, Chung WH, Cho YS, Hong SH. Early sensorineural hearing loss in ob/ob mouse, an animal model of type 2 diabetes. Clin Exp Otorhinolaryngol 2008;1:211–6.
- Akinpelu OV, Ibrahim F, Waissbluth S, Daniel SJ. Histopathologic changes in the cochlea associated with diabetes mellitus-a review. Otol Neurotol 2014;35:764–74.
- Shimada T, Kudo T, Akase T, Aburada M. Preventive effects of Bofutsushosan on obesity and various metabolic disorders. Biol Pharm Bull 2008;31:1362–7.
- Kawada T, Miyata S, Shimada T, Sanzen Y, Ito M, Hemmmi C, et al. A study of cardiovascular function in Tsumura Suzuki obese diabetes, a new model mouse of type 2 diabetes. Biol Pharm Bull 2010;33:998–1003.
- Iso T, Maeda K, Hanaoka H, Suga T, Goto K, Syamsunarno MR, et al. Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle. Arterioscler Thromb Vasc Biol 2013;33:2549–57.
- Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, Uysal KT, et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metabolism 2005;1:107–19.
- Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, et al. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation 2004;110:1492–8.